Bone mineral density screening should be routine in lymphoma patients

Affiliations

¹ Aurora Research Institute, Aurora Health Care, Milwaukee. Electronic address: michael.a.thompson@aurora.org.
² Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.

Free article

Comment

M A Thompson et al. Ann Oncol. 2014 Apr.

Free article

. 2014 Apr;25(4):913-914.

doi: 10.1093/annonc/mdu044.

¹ Aurora Research Institute, Aurora Health Care, Milwaukee. Electronic address: michael.a.thompson@aurora.org.
² Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.

No abstract available

Comment on

Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study.
Paccou J, Merlusca L, Henry-Desailly I, Parcelier A, Gruson B, Royer B, Charbonnier A, Ursu D, Desailloud R, Garidi R, Kamel S, Sevestre H, Marolleau JP, Fardellone P, Damaj G. Paccou J, et al. Ann Oncol. 2014 Feb;25(2):481-6. doi: 10.1093/annonc/mdt560. Epub 2014 Jan 8. Ann Oncol. 2014. PMID: 24401926